<html>
 <body>
  <div class="col-md-12" id="content" style="">
   <div class="hidden" data-drupal-messages-fallback="">
   </div>
   <div class="widget block" id="block-medsites-page-title">
    <h1>
     <span property="schema:name">
      Antimicrobial prophylaxis
     </span>
    </h1>
   </div>
   <div class="widget block" id="block-medsites-content">
    <article about="/commodorecompendium/antimicrobial-prophylaxis" data-history-node-id="2560" role="article" typeof="schema:WebPage">
     <div>
      <div class="field field--name-body field--type-text-with-summary field--label-hidden field__item" property="schema:text">
       <div style="border-bottom:solid windowtext 1.0pt; border-top:solid windowtext 1.0pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
        <p style="border:none; padding:0in">
         <span style="font-size:11pt">
          <span style="line-height:normal">
           <span style="font-family:Calibri,sans-serif">
            <b>
             <span style="font-size:12.0pt">
              <span style="font-family:Palatino">
               Antimicrobial Prophylaxis per CD4 Counts – Rachael Pellegrino
              </span>
             </span>
            </b>
           </span>
          </span>
         </span>
        </p>
       </div>
       <table class="TableGrid9" style="width:99.68%; border-collapse:collapse; border:none" width="99%">
        <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>0</th>
      <th>1</th>
      <th>2</th>
      <th>3</th>
      <th>4</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>CD4 counts</td>
      <td>Opportunistic Infection</td>
      <td>Indication for Prophylaxis</td>
      <td>Medication</td>
      <td>Special Notes</td>
    </tr>
    <tr>
      <td>&lt;200 cells/mm3</td>
      <td>Pneumocystis Pneumonia (PJP)</td>
      <td>CD4 &lt; 200, or CD4 &lt; 14%, or CD4 200-250 w/ delayed init. ART &amp; poor f/u</td>
      <td>TMP-SMX: 1 DS daily (qd), or TMP-SMX: 1SS qd TMP-SMX: 1 DS TIW</td>
      <td>If intolerant of TMP-SMX: dapsone*, or pentamidine, or atovaquone</td>
    </tr>
    <tr>
      <td>&lt;200 cells/mm3</td>
      <td>Toxoplasma gondii encephalitis</td>
      <td>Toxoplasma IgG + and CD4 &lt; 100</td>
      <td>TMP-SMX 1 DS tab daily</td>
      <td>Alternative regimens: Dapsone, or Atovaquone (all regimens effect. for PJP )</td>
    </tr>
    <tr>
      <td>&lt;200 cells/mm3</td>
      <td>Mycobacterium avium- intracellulare (MAC, MAI)</td>
      <td>Only if not on fully suppressive ART and active disseminated MAC is ruled out</td>
      <td>- Azithromycin 1200 mg weekly, or -Clarithromycin 500 mg BID, or - Rifabutin 300 mg daily</td>
      <td>NOT indicated for those initiating ART</td>
    </tr>
  </tbody>
</table>
       </table>
       <p style="margin-left:25px; text-indent:-9.35pt">
       </p>
       <p style="margin-left:25px; text-indent:-9.35pt">
       </p>
       <table class="TableGrid9" style="border-collapse:collapse; border:none">
        <table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th>Infection</th>
      <th>Screening Indication</th>
      <th>Intervention</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Hepatitis A Virus (HAV)</td>
      <td>Non-immune w/ ↑ risk for HAV infection (MSM, IVDU) or chronic liver disease</td>
      <td>HAV vaccine</td>
    </tr>
    <tr>
      <td>Hepatitis B Virus (HBV)</td>
      <td>Pts w/o chronic HBV or non-immune</td>
      <td>HBV vaccine. Ideally admin. before CD4 &lt; 350</td>
    </tr>
    <tr>
      <td>Human Papilloma virus (HPV)</td>
      <td>Age 13-45</td>
      <td>HPV vaccine series</td>
    </tr>
    <tr>
      <td>Influenza A and B Virus</td>
      <td>All patients</td>
      <td>Yearly inactivated influenza vaccine</td>
    </tr>
    <tr>
      <td>Latent Mycobacterium tuberculosis infection (LTBI)</td>
      <td>-Pts with positive screening test for LTBI w/ no evidence of active disease. -Pts w/ known exposure</td>
      <td>(INH 300mg + pyridoxine 25-50mg) PO daily for 9 months</td>
    </tr>
    <tr>
      <td>Streptococcus pneumoniae</td>
      <td>All patients</td>
      <td>PCV13 and PPV23 (order and timing depends on previous vaccination history and CD4)</td>
    </tr>
    <tr>
      <td>Syphilis</td>
      <td>All pts exposed to sex partner with syphilis diagnosis</td>
      <td>Screening for syphilis and gonorrhea/chlamydia with treatment if indicated.</td>
    </tr>
    <tr>
      <td>Varicella Zoster Virus (VZV)</td>
      <td>Pre-exposure: CD4&gt;200, no previous vaccine.Shingrix (recombinant vaccine) is not live virus, only Zostavax (live virus) is contraindicated for CD4 &lt;200). Post-exposure: Close contact, particularly if CD4 &lt;200</td>
      <td>Pre-exposure: Consider vaccination Post-exposure: Varicella-zoster immune globulin</td>
    </tr>
  </tbody>
</table>
       </table>
      </div>
     </div>
    </article>
   </div>
  </div>
 </body>
</html>